← All organizations
Zentalis Pharmaceuticals
For profitWebsite ↗
Also known as: K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc. | K-Group Alpha subsidiary of Zentalis Pharmaceuticals | K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc | Zentalis Pharmaceuticals
Highest phase reached
Phase 2
First clinical trial
Nov 30, 2021Last known activity
May 1, 2024
Timeline
2010s
- Jun 1, 2014
Zentalis Pharmaceuticals— Founded
Drugs by trial phase (8 distinct, 5 trials)
Phase 2 (7 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Recent trials (6)
- NCT06351332CollaboratorPhase 1/Phase 2May 1, 2024
- NCT05743036Lead sponsorPhase 1/Phase 2Feb 27, 2023
- NCT05431582CollaboratorPhase 1Dec 14, 2022
- NCT05682170Lead sponsorPhase 1/Phase 2Dec 1, 2022
- NCT05199337Lead sponsorPhase 1/Phase 2Nov 30, 2021
- NCT05199337Study directorPhase 1/Phase 2Nov 30, 2021
Details
- Founded
- San Diego, CA, US Jun 1, 2014
- Last known activity
- May 1, 2024